Mouse study demonstrates the ability of a cancer vaccine targeted against a specific oncogenic mutation to elicit a protective anti-tumor immune response.
Cranial irradiation, a common brain cancer treatment, disrupts neural morphology in mice in ways that resemble damage caused by neurodegenerative conditions.
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.